ASCENDIS HEALTH LIMITED - Change o the board: Retirement of Managing Director of South African Operations on 30 June 2018

Change o the board: Retirement of Managing Director of South African Operations on 30 June 2018

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
Share code: ASC ISIN: ZAE000185005
(“Ascendis” or “the Company”)

CHANGE TO THE BOARD OF DIRECTORS OF ASCENDIS: RETIREMENT OF MANAGING
DIRECTOR OF SOUTH AFRICAN OPERATIONS ON 30 JUNE 2018

In accordance with Section 3.59 of the JSE Listings Requirements, Ascendis shareholders are advised
that Mr Cliff Sampson, Managing Director of Ascendis’ South African operations, will reach his
retirement date on 30 June 2018 in accordance with the terms of his employment contract.

As a consequence of the conclusion of his employment contract, Mr Sampson will retire from the
board of directors of Ascendis (the “Board”) as an executive director and as managing director of the
Ascendis South African operations on 30 June 2018. Mr Sampson has made himself available post his
retirement to ensure a smooth and successful handover.

The Board is in the process of securing a replacement executive and will manage the process to
ensure a phased hand-over of accountabilities and responsibilities. This process will take into account
the Company’s transformation principles. The South African division is well supported by a strong
executive team in the Phyto-Vet, Pharma, Medical Devices and Consumer Brands business units and
has invested heavily in its human capital over the past 4 years.

The board would like to thank Mr Sampson for his contribution and dedicated service to Ascendis and
wishes him well with his retirement.



31 October 2017

Johannesburg
Sponsor
Investec Bank Limited

Date: 31/10/2017 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.